Classification and risk stratification in T-lineage acute lymphoblastic leukemia

Petri Pölönen,Charles G Mullighan,David Trent Teachey
DOI: https://doi.org/10.1182/blood.2023022920
IF: 20.3
2024-10-03
Blood
Abstract:Cure rates for patients with acute lymphoblastic leukemia (ALL) have improved markedly in recent decades, in part due to risk stratification incorporating leukemia genomics, response to treatment, and clinical features to be able to determine at diagnosis which patients are more likely to relapse or have refractory disease. While risk stratification is well-developed for patients with B lineage ALL (B-ALL), it remains challenging for those with T lineage ALL (T-ALL). Prognostic factors validated...
hematology
What problem does this paper attempt to address?